Industry Veterans from Monsanto, Corteva, Cornell, and others guide the advancement of the targeted recombination technology platform Meiogenix, a biotechnology company harnessing epigenetics and ...
2016 was the year of the unexpected; 2017 is the year of volatility. Genpact CEO N. V. Tyagarajan sees the dangers, but also the opportunities for driving digital transformation. As we've seen in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback